USE OF MOLECULAR TUMOUR MARKERS TO IMPROVE DIAGNOSTIC PERFORMANCE OF BRONCHOSCOPY IN ASSESSMENT OF PULMONARY NODULES AND EARLY DIAGNOSIS OF LUNG CANCER
Grant number: 1121880 | Funding period: 2017 - 2020
Pulmonary nodules may represent early lung cancer though difficulty in accurate diagnosis means many patients experience delayed diagnosis, or unnecessary surgical biopsy or repeat CT imaging (& consequent radiation exposure). I will identify molecular (DNA, protein) markers in bronchoscopic & blood specimens to accurately characterize malignant & benign nodules. These biomarkers will also be investigated for their value as a non-invasive screening test for lung cancer
Related publications (2)
Harnessing Natural Killer Immunity in Metastatic SCLC
Sarah A Best, Jonas B Hess, Fernando Souza-Fonseca-Guimaraes, Joseph Cursons, Ariena Kersbergen, Xueyi Dong, Jai Rautela, Stephanie R Hyslop, Matthew E Ritchie, Melissa J Davis, Tracy L Leong, Louis Irving, Daniel Steinfort, Nicholas D Huntington, Kate D Sutherland
INTRODUCTION: SCLC is the most aggressive subtype of lung cancer, and though most patients initially respond to platinum-based che..
Systematic endobronchial ultrasound-guided transbronchial needle aspiration improves radiotherapy planning in non-small cell lung cancer
Aidan Joseph Cole, Nicholas Hardcastle, Guy-Anne Turgeon, Roshini Thomas, Louis B Irving, Barton R Jennings, David Ball, Tomas Kron, Daniel P Steinfort, Shankar Siva
Objectives: Patients suitable for radical chemoradiotherapy for lung cancer routinely have radiotherapy (planning) volumes based o..